SCHEMBL8568538

SCHEMBL8568538

CC(C)(C)OC(=O)NNC=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.42
APLNR P35414 1/20 0.42
CTSK P43235 3/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MIF P14174 1/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
DGAT1 O75907 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27664700 0.80 GAA (0.45) GAAAPLNRCTSKMEN1KMT2A
SCHEMBL23956464 0.80 GAA (0.41) GAAAPLNRCTSKMEN1KMT2A
SCHEMBL284141 0.80 APLNR (0.55) GAAAPLNRMEN1KMT2AMIF
SCHEMBL5729371 0.76 CTSK (0.42) GAAAPLNRCTSKMEN1KMT2A
SCHEMBL11525177 0.75 MEN1 (0.56) GAAAPLNRMEN1KMT2AMIF
SCHEMBL8520807 0.75 APLNR (0.47) GAAAPLNRMEN1KMT2AMIF
SCHEMBL4150198 0.75 APLNR (0.47) GAAAPLNRMEN1KMT2AMIF
SCHEMBL18935521 0.74 GAA (0.37) GAAAPLNRCTSKMEN1KMT2A
SCHEMBL289320 0.73 APLNR (0.46) GAAAPLNRMEN1KMT2AMIF
SCHEMBL24514107 0.73 APLNR (0.50) GAAAPLNRMEN1KMT2AMIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863881-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-09-16 EP claimed
WO-1997010219-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-03-20 WO claimed
EP-3634406-B1 3,4,5-TRISUBSTITUTED-1,2,4-TRIAZOLES AND 3,4,5-TRISUBSTITUTED-3-THIO-1,2,4-TRIAZOLES AND USES THEREOF BOARD OF TRUSTEES OF THE SOUTHERN ILLINOIS UNIV ON BEHALF OF SOUTHERN ILLINOIS UNIV EDWARDSVILLE (US) 2023-09-06 EP disclosed
EP-3743411-B1 HERBICIDAL 3-PHENYLISOXAZOLIN-5-CARBOXAMIDES OF CYCLOPENTENYL CARBOXYLIC ACID DERIVATIVES BAYER AG (DE) 2022-12-21 EP disclosed
WO-2021255174-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2021-12-23 WO disclosed
EP-3408257-A1 LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES Belyntic GmbH (DE) 2018-12-05 EP disclosed
EP-2470215-B1 BISPHOSPHONATE-PRODRUGS VERGELL MEDICAL S A (CH) 2018-04-25 EP disclosed
CN-100354276-C Biologically active compounds AMURA THERAPEUTICS LTD (GB) 2007-12-12 CN disclosed
CN-1681817-A Biologically active compounds AMURA THERAPEUTICS LTD (GB) 2005-10-12 CN disclosed
EP-0863881-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-09-16 EP disclosed
WO-1997010219-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE IN THE PREVENTION AND/OR THE TREATMENT OF BONE DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-03-20 WO disclosed